Skip to content
The Nexus
DossierENTITY

Chinese lung cancer therapy

Coverage of Chinese lung cancer therapy in the Nexus archive.

Earliest in view: Jun 1 · 13:12 UTCMost recent: Jun 1 · 13:12 UTC
Co-mentioned in this coverage
Recent coverage
  • HEALTHJun 1 · 13:12 UTCSTAT NEWS
    STAT+: A turning point for pancreatic cancer patients

    The article highlights recent advancements in pancreatic cancer treatment, including detailed results from daraxonrasib trials, and a Chinese lung cancer therapy exceeding expectations. It also discusses regulatory debates over a long-standing peptide used by biohackers.

Chinese lung cancer therapy · Dossier · The Nexus